Purchase Order 75N95025P00023
- Not listed
- This is a $20,000 firm-fixed-price purchase order awarded to Transnetyx, Inc. by the National Institute on Drug Abuse, a component of the Department of Health and Human Services. The contract is for Transnetyx's genotyping services to support biomedical research efforts. Transnetyx, a for-profit organization, specializes in DNA extraction, multi-gene analysis, bioinformatics, and automated genotyping services, primarily serving various NIH institutes. The contract is not set-aside. Transnetyx...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Transnetyx, Inc. The contract, valued at $24,999.00, is for automated genotyping services to support research examining the behavior and cellular mechanisms of learning in addiction. Transnetyx, a for-profit organization, provides a range of genomic services to federal agencies, including DNA extraction, gene analysis, and...
- This federal contract award is for genotyping services to be provided by Transnetyx, Inc., a for-profit organization based in Cordova, Tennessee. The contract, valued at $18,784.75, was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price, and the services are to be delivered over a one-year period ending on September 12, 2025. The contract was...
- This firm-fixed-price purchase order, valued at $24,487.45, was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services to support biomedical research. The contract, which has no set-aside designation, is for genotyping testing services to support NIDA's research initiatives. Transnetyx has held numerous federal contracts to provide genomic...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services. The $18,000.00 contract is for genotyping services to support biomedical research efforts across various federal agencies. Transnetyx has extensive experience supporting NIH institutes, including NIDA, the National Institute of Neurological...
- This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization headquartered in Cordova, Tennessee. The contract has a ceiling value of $117,136.20 and was awarded on a firm-fixed-price basis. It is not designated as a set-aside contract. The contract provides for Transnetyx to deliver automated genotyping, DNA extraction, multi-gene analysis, and bioinformatics...
- This is a federal contract award by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The contract is for $7,848.00 and is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call to provide genotyping services for probes for the entire fiscal year 2018. The contract has an ultimate completion date of October 13, 2023...
- This federal contract award is for genotyping services provided by Transnetyx, Inc., a for-profit organization based in Cordova, Tennessee. The contract was awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $19,903.75 and a firm fixed price pricing type. The contract has an ultimate completion date of March 18, 2025. Transnetyx is an established...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The $9,395.90 firm fixed-price contract provides genotyping services to NIDA during Fiscal Year 2018. This contract is not associated with a set-aside designation, indicating open market competition. Transnetyx, headquartered in...
- This federal contract award to Transnetyx, Inc. is for PCR for genotyping services, with a ceiling value of $14,000 and a completion date of February 7, 2025. The contract is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx, Inc., a for-profit organization specializing in automated genotyping, DNA extraction, and bioinformatics services, has extensive experience supporting...
This is a $15,000 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization headquartered in Cordova, Tennessee. The contract is not set aside and has a completion date of February 19, 2026. Transnetyx is a provider of automated genotyping, DNA extraction, multi-gene analysis, and bioinformatics services primarily for biomedical research purposes, supporting various NIH institutes and centers. This contract is part of Transnetyx's broader portfolio of federal awards, which includes several significant Indefinite Delivery Vehicles (IDVs) worth up to $10 million, $1.465 million, and $7 million, enabling the company to deliver consistent, high-quality genomic analysis services across a range of research programs examining areas such as neurological disorders, environmental health, substance abuse, and age-related conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $5.0k | 3/24/25 | |
| Not listed | Not listed | $10.0k | 11/19/24 |